Cited by 2,355CRISPR and Genetic EngineeringAnimal Genetics and ReproductionBacterial Genetics and Biotechnology

Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells

Thomas, Kirk R., Capecchi, Mario R.·1987·Cell

Abstract

We mutated, by gene targeting, the endogenous hypoxanthine phosphoribosyl transferase (HPRT) gene in mouse embryo-derived stem (ES) cells. A specialized construct of the neomycin resistance (neor) gene was introduced into an exon of a cloned fragment of the Hprt gene and used to transfect ES cells. Among the G418r colonies, 1/1000 were also resistant to the base analog 6-thioguanine (6-TG). The G418r, 6-TGr cells were all shown to be Hprt- as the result of homologous recombination with the exogenous, neor-containing, Hprt sequences. We have compared the gene-targeting efficiencies of two classes of neor-Hprt recombinant vectors: those that replace the endogenous sequence with the exogenous sequence and those that insert the exogenous sequence into the endogenous sequence. The targeting efficiencies of both classes of vectors are strongly dependent upon the extent of homology between exogenous and endogenous sequences. The protocol described herein should be useful for targeting mutations into any gene.

Integrity signals

Registry

Crossref · 10.1016/0092-8674(87)90646-5

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Due to the extremely low frequency of homologous recombination, this technique cannot be used for human gene therapy.

    “However, due to the extremely low frequency of HR, this technique cannot be used for human gene therapy.”

    From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [13]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Thomas, K. R., & Capecchi, M. R.
Affiliations
University of Utah (US)
Venue
Cell
Publisher
Elsevier BV
Published
1987-11
Volume
51
Issue
3
Pages
503-512
ISSN
0092-8674 (ISSN-L)
OpenAlex
W1993834457
Cited by
2,355
References
35
Citations by year
2026: 11 · 2025: 21 · 2024: 27 · 2023: 31 · 2022: 40 · 2021: 50 · 2020: 55 · 2019: 46 · 2018: 49 · 2017: 47 · 2016: 61 · 2015: 74 · 2014: 51 · 2013: 69 · 2012: 71
FWCI
17.35
Type
journal article
Language
en
Open access
closed
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
Funders
Cystic Fibrosis Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
Tn10 transposon, transposon ends, type II restriction endonuclease, protein-DNA recognition, DNA cleavage, site-directed mutagenesis, gene targeting
MeSH terms
Animals, Blastocyst, Cells, Cultured, DNA Restriction Enzymes, Genes, Genetic Vectors, Hematopoietic Stem Cells, Hypoxanthine Phosphoribosyltransferase, Mice, Inbred C57BL, Mutation, Nucleic Acid Hybridization, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review